日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient

功能性同源重组 (HR) 筛选表明,大多数 BRCA1/2 突变型乳腺癌和卵巢癌细胞系均具有 HR 功能

Titia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen, Nicole S Verkaik, Corine M Beaufort, Stanley van Herk, Teresa Robert-Finestra, Remco M Hoogenboezem, Kirsten Ruigrok-Ritstier, Maarten W Paul, Joost Gribnau, Eric M J Bindels, Roland Kanaar, Agnes Jager, Dik C van Gent, Antoinette H

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile

来自 CHEK2 c.1100delC 突变携带者的乳腺癌基因组缺乏体细胞 TP53 突变,并表现出独特的结构变异大小分布特征。

Smid, Marcel; Schmidt, Marjanka K; Prager-van der Smissen, Wendy J C; Ruigrok-Ritstier, Kirsten; Schreurs, Maartje A C; Cornelissen, Sten; Garcia, Aida Marsal; Broeks, Annegien; Timmermans, A Mieke; Trapman-Jansen, Anita M A C; Collée, J Margriet; Adank, Muriel A; Hooning, Maartje J; Martens, John W M; Hollestelle, Antoinette

The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer

ESR1融合基因转录本在原发性乳腺癌中的预后和预测价值

Vitale, Silvia R; Ruigrok-Ritstier, Kirsten; Timmermans, A Mieke; Foekens, Renée; Trapman-Jansen, Anita M A C; Beaufort, Corine M; Vigneri, Paolo; Sleijfer, Stefan; Martens, John W M; Sieuwerts, Anieta M; Jansen, Maurice P H M

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

循环HPV DNA作为宫颈癌患者复发早期检测的标志物

Jeannot, Emmanuelle; Latouche, Aurélien; Bonneau, Claire; Calméjane, Marie-Ange; Beaufort, Corine; Ruigrok-Ritstier, Kirsten; Bataillon, Guillaume; Larbi Chérif, Linda; Dupain, Célia; Lecerf, Charlotte; Popovic, Marina; de la Rochefordière, Anne; Lecuru, Fabrice; Fourchotte, Virginie; Jordanova, Ekaterina S; von der Leyen, Heiko; Tran-Perennou, Carine; Legrier, Marie-Emmanuelle; Dureau, Sylvain; Raizonville, Laurence; Bello Roufai, Diana; Le Tourneau, Christophe; Bièche, Ivan; Rouzier, Roman; Berns, Els M J J; Kamal, Maud; Scholl, Suzy

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

ABAT 和 STC2 表达降低是 ER 阳性炎性乳腺癌和晚期疾病内分泌治疗耐药性的标志

Maurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, Caroline Van Cauwenberghe, Diana Ramirez-Ardila, Maxime Look, Kirsten Ruigrok-Ritstier, Pascal Finetti, François Bertucci, Mieke M Timmermans, Carolien H M van Deurzen, John W M Martens, Iris Simon, Paul Roepman, Sabine C Linn, Peter van Dam, Marle

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

miR-26a水平升高和CDC2水平降低与EZH2表达降低以及转移性乳腺癌患者服用他莫昔芬治疗的良好预后相关。

Jansen, M P H M; Reijm, E A; Sieuwerts, A M; Ruigrok-Ritstier, K; Look, M P; Rodríguez-González, F G; Heine, A A J; Martens, J W; Sleijfer, S; Foekens, J A; Berns, E M J J

LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment

乳腺肿瘤组织中LH受体基因表达基本缺失:对治疗的启示

Kuijper, T Martijn; Ruigrok-Ritstier, Kirsten; Verhoef-Post, Miriam; Piersma, Djura; Bruysters, Martijn W P; Berns, Els M J J; Themmen, Axel P N